Increased bone marrow CD56bright natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome

Increased bone marrow CD56^bright natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome

Bone Marrow Transplant. 2019 Jun;54(6):924-927. doi: 10.1038/s41409-018-0407-y. Epub 2018 Dec 18.

Ren Ching Wang^{1

2}, Shahram Mori³, Xiang Zhu⁴, Juan Carlos Varela⁵, Debbie Dickman¹, Rushang Patel⁵, David Ward¹, Steven C Goldstein⁵, Chun-Che Chang^{1

6}

¹ Department of Pathology and Laboratory Medicine, Florida Hospital, Orlando, FL, USA.
² Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
³ Blood and Marrow Transplant Center, Florida Hospital, Orlando, FL, USA. Shahram.mori.md@flhosp.org.
⁴ Research Analytics Institute, Florida Hospital, Orlando, FL, USA.
⁵ Blood and Marrow Transplant Center, Florida Hospital, Orlando, FL, USA.
⁶ Department of Pathology, College of Medicine, University of Central Florida, Orlando, FL, USA.

No abstract available